Skip to main content
FinSpry Logo
FinSpry
ASTH logo
ASTH
(NASDAQ)
Astrana Health, Inc.
$38.76-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Astrana Health (ASTH) Stock Price & Financial Analysis

Astrana Health Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$37.92 - $39.87
52-Week High$39.90
52-Week Low$18.08
Open$39.30
Volume327.19K
Average Volume (3M)478.77K
Market Cap1.95B
Shares Outstanding49.53M
P/E Ratio (TTM)86.56
Forward P/E153.10
Price to Sales (P/S)0.61
Price to Book (P/B)2.50
EV/EBITDA20.17
Revenue (TTM)3.18B
Net Income (TTM)22.49M
Free Cash Flow (TTM)104.49M
EPS (TTM)$0.49
Profit Margin0.71%
Operating Margin2.47%
Return on Equity (ROE)2.89%
Debt to Equity1.38
50-Day MA$28.86
200-Day MA$26.86
52-Week Change33.04%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Astrana Health

What is the current stock price for ASTH?

As of the latest trading session, ASTH stock trades at $38.76. The 52-week range is $18.08–$39.90, with a day range of $37.92–$39.87.

What is the P/E ratio for ASTH?

Astrana Health's trailing P/E ratio is 86.6, meaning investors pay $86.6 for every $1 of annual earnings. The forward P/E is 153.1, reflecting analyst expectations for future earnings.

Does ASTH pay dividends?

Astrana Health does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ASTH?

Based on 6 analysts, the consensus for ASTH is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ASTH?

Astrana Health's market capitalization is $1.92B, classifying it as a small-cap company..